Commentary

Ethics panels need to keep pace with trial reform

Read more

Collaboration to deliver superior value to patients

Read more

Getting traction against antimicrobial resistance

Read more

Expanding medicine access through formulation

Read more

Genomic Research - What IP filings show about the major players

Read more

Commentary: Alphabodies - working inside the cell

Read more

The case for allogeneic cell therapy

Read more

Clinical and market issues for cell-based therapies

Read more

Why the time has come for MidPharmas

Read more